Ovarian Cancer Action has funded £12.3 million of research projects since we began in 2006. Our scientists at the OCA Research Centre and the University of Oxford are now working on the next generation of research that will prevent ovarian cancer, catch it early and treat it effectively.
Find out more
Get to know the brains behind the work we fund
Ovarian cancer research starts and ends with you
Our research strategy ensures that every penny we invest in research goes towards the science that will transform how well and how long women will live
Every four years, we bring together the world’s leading ovarian cancer experts to discuss and debate what we need to do to make ovarian cancer a survivable disease.
Immunotherapy is a cancer treatment that turns the body’s immune system against cancer. Some types of immunotherapy are also referred to as targeted therapies.
Learn more about why we are investing in immunotherapy research.
Find out moreJoin our newsletter, be the first to read our equality reports and stay up-to-date with the latest news and information from Ovarian Cancer Action.